NDC 0486-1134 K-phos No. 2

Potassium Phosphate,Monobasic And Sodium Phosphate,Monobasic,Anhydrous Tablet, Coated Oral - View Dosage, Usage, Ingredients, Routes, UNII

Product Information

NDC Product Code:
0486-1134
Proprietary Name:
K-phos No. 2
Non-Proprietary Name: [1]
Potassium Phosphate, Monobasic And Sodium Phosphate, Monobasic, Anhydrous
Substance Name: [2]
Potassium Phosphate, Monobasic; Sodium Phosphate, Monobasic, Anhydrous
NDC Directory Status:
Human Prescription Drug
Product Type: [3]
ACTIVE PRODUCT INCLUDED in the NDC Directory
Dosage Form:
Tablet, Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is covered with a designated coating.
Administration Route(s): [4]
  • Oral - Administration to or by way of the mouth.
  • Labeler Code:
    0486
    Marketing Category: [8]
    UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
    Start Marketing Date: [9]
    05-09-1978
    Listing Expiration Date: [11]
    12-31-2024
    Exclude Flag: [12]
    N
    Code Navigator:

    Product Characteristics

    Color(s):
    BROWN (C48332)
    Shape:
    OVAL (C48345)
    Size(s):
    19 MM
    Imprint(s):
    BEACH;11;34
    Score:
    1

    Code Structure Chart

    Product Details

    What is NDC 0486-1134?

    The NDC code 0486-1134 is assigned by the FDA to the product K-phos No. 2 which is a human prescription drug product labeled by Beach Products, Inc.. The generic name of K-phos No. 2 is potassium phosphate, monobasic and sodium phosphate, monobasic, anhydrous. The product's dosage form is tablet, coated and is administered via oral form. The product is distributed in a single package with assigned NDC code 0486-1134-01 100 tablet, coated in 1 bottle . This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

    What are the uses for K-phos No. 2?

    This product is contraindicated in patients with infected phosphate stones, in patients with severely impaired renal function (less than 30% of normal) and in the presence of hyperphosphatemia.

    What are K-phos No. 2 Active Ingredients?

    An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

    Which are K-phos No. 2 UNII Codes?

    The UNII codes for the active ingredients in this product are:

    • POTASSIUM PHOSPHATE, MONOBASIC (UNII: 4J9FJ0HL51)
    • PHOSPHATE ION (UNII: NK08V8K8HR) (Active Moiety)
    • POTASSIUM CATION (UNII: 295O53K152) (Active Moiety)
    • SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS (UNII: KH7I04HPUU)
    • SODIUM CATION (UNII: LYR4M0NH37) (Active Moiety)

    Which are K-phos No. 2 Inactive Ingredients UNII Codes?

    The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

    What is the NDC to RxNorm Crosswalk for K-phos No. 2?

    RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
    • RxCUI: 209224 - K-Phos No 2 305 MG / 700 MG Oral Tablet
    • RxCUI: 209224 - potassium phosphate 305 MG / sodium phosphate, monobasic 700 MG Oral Tablet [K-Phos No 2]
    • RxCUI: 209224 - K+ phosphate 305 MG / Sodium Phosphate, Monobasic 700 MG Oral Tablet [K-Phos No 2]
    • RxCUI: 209224 - K-Phos No 2 (potassium phosphate 305 MG / sodium phosphate, monobasic 700 MG) Oral Tablet
    • RxCUI: 209224 - Pot phosphate 305 MG / Sodium Phosphate, Monobasic 700 MG Oral Tablet [K-Phos No 2]

    * Please review the disclaimer below.

    Product Footnotes

    [1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.

    [2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

    [3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

    [4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.

    [5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

    [8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

    [9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

    [11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

    [12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".